Editorial draft · writing/sandoz-and-the-world-supply
The Day the Manufacturer Lost Control
Education, not medical advice. Drafts and study material from an independent research library. Citations on this page were checked on Oct 13, 2026; claims in the body text and organizational sources are still under review. What was checked.
The Day the Manufacturer Lost Control
“In 1953, the CIA purchased the entire world supply of LSD from the manufact…”historypolicy
“In 1953, the CIA purchased the entire world supply of LSD from the manufacturer, enough for an enormous number of doses. The manufacturer was relieved to sell it. They had no idea what to do with it.”
Albert Hofmann's problem child became the world's problem almost immediately after it left the laboratory.
the Basel drug company had been distributing LSD-25 since 1947 under a trade name, primarily to psychiatric researchers studying schizophrenia and alcoholism. By 1953, word had spread beyond the academic psychiatric community. The CIA's Technical Services Division, which was running MK-Ultra under Sidney Gottlieb, learned about LSD's extreme potency and psychological effects and decided it needed to control the supply.
They bought it all. The entire global stock, for an amount the manufacturer considered reasonable. This was enough for an enormous number of doses. Gottlieb's goal was to determine whether LSD could be used as a truth serum, an interrogation tool, a method for temporarily incapacitating enemies, or a vector for inducing psychiatric disorders in targets.
The answers, after a decade of human experimentation including MK-Ultra's various subprojects, were: no, no, no, and unreliably. The CIA's LSD program produced no usable intelligence techniques. It produced a death (Frank Olson in 1953), extensive psychological damage to unwitting subjects, and eventually a political scandal when the Church Committee exposed the program in 1975.
Hofmann, describing this period in My Problem Child, is characteristically measured. He understood that the company had no means to control what happened to LSD once it left the laboratory, the chemistry was publishable, the synthesis was reproducible, and the demand created by the drug's effects was not something a pharmaceutical company could manage. The CIA's purchase was one symptom. Leary's mass distribution was another. The street market that emerged in the 1960s was a third.
What the company could control, and eventually did, was its own production. In 1965, as the counterculture's use of LSD became impossible to ignore, the manufacturer stopped making it. By then, illicit synthesis labs had been running for years. The problem child had left home.
Sources
- Stevens, Jay. Storming Heaven (1987)
- Marks, John. The Search for the Manchurian Candidate (1979)
- Hofmann, LSD: My Problem Child (1979)
Links for this item
- Posts
- No post is recorded for this item yet.
- Source page
- The sources for this item on RN Collins Selected Work
- Long-form
- This page is the full draft.
- Gallery
- See it in the gallery index
- Project
- About this library on RN Collins Selected Work
- Corrections
- Publication rules and the correction form
Reading list for this book
- Reading list: LSD: My Problem Child Reading list
NotebookLM packs on this book
- April 19, 1943 NotebookLM source pack
Bridge pieces that use this book
- María Sabina and the Machine Elves: Two Accounts of Encountering the Other Bridge piece
- The Sacred Drug and the Dominator Drug: Hofmann and McKenna on Alcohol Bridge piece
Science annotations on this book
- A single psychedelic session can produce lasting psychological change persisting for months or years, not... Science annotation
Then vs. Now comparisons on this book
- LSD Potency: The Threshold Claim Then vs. Now comparison
- LSD and Mystical Experience: Hofmann's Claim Then vs. Now comparison
- LSD as Sacred Drug: The 1965 Prohibition Then vs. Now comparison
- Bicycle Day Chemistry: What Hofmann Synthesized Then vs. Now comparison
- LSD and the Law: Hofmann's Hope for Rescheduling Then vs. Now comparison
- LSD in Switzerland 2026: The Country That Never Stopped Then vs. Now comparison
- LSD's Crystal Structure and the Duration Mechanism Then vs. Now comparison
- Cluster Headaches and LSD: The Orphan Indication Hofmann Didn't Know About Then vs. Now comparison
- MDMA and LSD: Hofmann's Two 'Problem Children' Then vs. Now comparison
- The Neuroplasticity Mechanism: What Hofmann Couldn't Have Known Then vs. Now comparison
Claims from this book
- Mystical experience quality predicts therapeutic outcomes better than drug dose alone Claim
- Hofmann's LSD is best understood as a 'sacred drug' rather than a psychiatric tool Claim
- FDA approval of psilocybin-assisted therapy would make it broadly accessible to patients who need it Claim
- LSD is not addictive in the conventional sense, it does not produce physical dependence or compulsive use... Claim
- LSD microdosing (sub-perceptual doses) produces measurable cognitive benefits Claim
- A single psilocybin session can produce lasting reduction in tobacco addiction Claim
Other pages in this library that link here
- The First Contacts Course module
- The Science of the Experience Course module
- The Suppression Course module
- Psychedelic Science for Science Writers Teaching module